Document is current
Any future updates will be listed below
-
Authors
Yan, Yuqian
Ma, Jian
Wang, Dejie
Lin, Dong
Pang, Xiaodong
Wang, Shangqian
Zhao, Yu
Shi, Lei
Xue, Hui
Pan, Yunqian
Zhang, Jun
Wahlestedt, Claes
Giles, Francis J
Chen, Yu
Gleave, Martin E
Collins, Collin C
Ye, Dingwei
Wang, Yuzhuo https://orcid.org/0000-0002-9749-8591
Huang, Haojie https://orcid.org/0000-0003-2751-6413
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA134514)
Foundation for the National Institutes of Health (CA130908)
Foundation for the National Institutes of Health (CA193239)
Foundation for the National Institutes of Health (CA203849)
The Mayo Clinic Foundation
Canadian Institutes of Health Research Operating Grants (141635)
Canadian Institutes of Health Research Operating Grants (144159)
Canadian Institutes of Health Research Operating Grants (153081)
Terry Fox Research Institute Program Project (1062)
National Natural Science Foundation of China (81672544)
National Natural Science Foundation of China (81872099)
Epigene Therapeutics Inc
- License Information
-
More Information
Article History
Received: 25 March 2019
Revised: 23 August 2019
Accepted: 4 September 2019
First Online: 26 September 2019
Conflict of interest
: H.H. received research funding from Epigene Therapeutics Inc (Montreal, QC, Canada) and F.G. formerly served as a consultant to, and has equity interest in, Epigene Therapeutics Inc. C.W. is a co‐founder of Epigenetix Inc. The authors declare that they otherwise have no conflict of interest.
